BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17545803)

  • 1. Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma.
    George SL; Parmar V; Lorenzi F; Marshall LV; Jamin Y; Poon E; Angelini P; Chesler L
    J Exp Clin Cancer Res; 2020 May; 39(1):78. PubMed ID: 32375866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cells, immortality, and the evolution of metastatic properties in breast cancer: telomere maintenance mechanisms and metastatic evolution.
    Robinson NJ; Taylor DJ; Schiemann WP
    J Cancer Metastasis Treat; 2019; 5():. PubMed ID: 31440584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.
    Lovejoy CA; Li W; Reisenweber S; Thongthip S; Bruno J; de Lange T; De S; Petrini JH; Sung PA; Jasin M; Rosenbluh J; Zwang Y; Weir BA; Hatton C; Ivanova E; Macconaill L; Hanna M; Hahn WC; Lue NF; Reddel RR; Jiao Y; Kinzler K; Vogelstein B; Papadopoulos N; Meeker AK;
    PLoS Genet; 2012; 8(7):e1002772. PubMed ID: 22829774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors.
    Flynn RL; Cox KE; Jeitany M; Wakimoto H; Bryll AR; Ganem NJ; Bersani F; Pineda JR; Suvà ML; Benes CH; Haber DA; Boussin FD; Zou L
    Science; 2015 Jan; 347(6219):273-7. PubMed ID: 25593184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of wild-type ATRX expression in somatic cell hybrids segregates with activation of Alternative Lengthening of Telomeres.
    Bower K; Napier CE; Cole SL; Dagg RA; Lau LM; Duncan EL; Moy EL; Reddel RR
    PLoS One; 2012; 7(11):e50062. PubMed ID: 23185534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered telomeres in tumors with ATRX and DAXX mutations.
    Heaphy CM; de Wilde RF; Jiao Y; Klein AP; Edil BH; Shi C; Bettegowda C; Rodriguez FJ; Eberhart CG; Hebbar S; Offerhaus GJ; McLendon R; Rasheed BA; He Y; Yan H; Bigner DD; Oba-Shinjo SM; Marie SK; Riggins GJ; Kinzler KW; Vogelstein B; Hruban RH; Maitra A; Papadopoulos N; Meeker AK
    Science; 2011 Jul; 333(6041):425. PubMed ID: 21719641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative lengthening of telomeres pathway: recombination-mediated telomere maintenance mechanism in human cells.
    Nabetani A; Ishikawa F
    J Biochem; 2011 Jan; 149(1):5-14. PubMed ID: 20937668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PML body meets telomere: the beginning of an ALTernate ending?
    Chung I; Osterwald S; Deeg KI; Rippe K
    Nucleus; 2012; 3(3):263-75. PubMed ID: 22572954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts.
    Brems-Eskildsen AS; Zieger K; Toldbod H; Holcomb C; Higuchi R; Mansilla F; Munksgaard PP; Borre M; Ørntoft TF; Dyrskjøt L
    BMC Cancer; 2010 Nov; 10():646. PubMed ID: 21106093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomeres do the (un)twist: helicase actions at chromosome termini.
    Chavez A; Tsou AM; Johnson FB
    Biochim Biophys Acta; 2009 Apr; 1792(4):329-40. PubMed ID: 19245831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of telomeres and promyelocytic leukemia nuclear bodies in a telomerase-negative human cell line.
    Jegou T; Chung I; Heuvelman G; Wachsmuth M; Görisch SM; Greulich-Bode KM; Boukamp P; Lichter P; Rippe K
    Mol Biol Cell; 2009 Apr; 20(7):2070-82. PubMed ID: 19211845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of circular telomeric DNA without 2D gel electrophoresis.
    Dlaska M; Anderl C; Eisterer W; Bechter OE
    DNA Cell Biol; 2008 Sep; 27(9):489-96. PubMed ID: 18694327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mating type influences chromosome loss and replicative senescence in telomerase-deficient budding yeast by Dnl4-dependent telomere fusion.
    Meyer DH; Bailis AM
    Mol Microbiol; 2008 Sep; 69(5):1246-54. PubMed ID: 18627461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere maintenance in sarcomas.
    Johnson JE; Broccoli D
    Curr Opin Oncol; 2007 Jul; 19(4):377-82. PubMed ID: 17545803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomeres and telomerase in sarcomas.
    Matsuo T; Shimose S; Kubo T; Fujimori J; Yasunaga Y; Ochi M
    Anticancer Res; 2009 Oct; 29(10):3833-6. PubMed ID: 19846916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
    Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?
    Nittis T; Guittat L; Stewart SA
    Biochimie; 2008 Jan; 90(1):5-12. PubMed ID: 17935854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple mechanisms of telomere maintenance exist in liposarcomas.
    Johnson JE; Varkonyi RJ; Schwalm J; Cragle R; Klein-Szanto A; Patchefsky A; Cukierman E; von Mehren M; Broccoli D
    Clin Cancer Res; 2005 Aug; 11(15):5347-55. PubMed ID: 16061847
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.